Characteristics | |
Age yrs | 63 (32–89) |
Sex | |
Male | 372 (72.5) |
Female | 141 (27.5) |
Disease stage |
III | 123 (24.0) |
IV | 384 (74.8) |
Other | 6 (1.2) |
WHO performance status | |
Good (0–1) | 191 (37.3) |
Intermediate (2) | 133 (25.9) |
Poor (3–4) | 73 (14.2) |
Unknown | 116 (22.6) |
Smoking status | |
Never | 40 (7.8) |
Ever | 448 (87.3) |
Unknown | 25 (4.9) |
Histology | |
Adenocarcinoma | 252 (49.1) |
AD/BAC | 34 (6.7) |
Squamous cell | 135 (26.3) |
Other NSCLC | 92 (17.9) |
Prior local treatment | |
Yes | 230 (44.8) |
No | 283 (55.2) |
Prior chemotherapy regimens | |
0 | 42 (8.2) |
1 | 170 (33.1) |
≥2 | 301 (58.7) |
Prior chemotherapy agents | |
Platinum | 418 (81.5) |
Taxane | 260 (50.7) |
Gemcitabine | 366 (71.4) |
Vinorelbine | 155 (30.2) |
Other | 177 (34.5) |